Kimitaka Shibue

866 total citations
26 papers, 670 citations indexed

About

Kimitaka Shibue is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Kimitaka Shibue has authored 26 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Kimitaka Shibue's work include Diabetes Treatment and Management (9 papers), Pancreatic function and diabetes (8 papers) and Pituitary Gland Disorders and Treatments (5 papers). Kimitaka Shibue is often cited by papers focused on Diabetes Treatment and Management (9 papers), Pancreatic function and diabetes (8 papers) and Pituitary Gland Disorders and Treatments (5 papers). Kimitaka Shibue collaborates with scholars based in Japan, United States and Canada. Kimitaka Shibue's co-authors include Nobuya Inagaki, Kazuyo Suzuki, Shunsuke Yamane, Norio Harada, Akihiro Hamasaki, Takanari Harada, Erina Joo, Kanako Iwasaki, Daniela Nasteska and Akiko Sankoda and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Diabetes.

In The Last Decade

Kimitaka Shibue

21 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimitaka Shibue Japan 12 369 284 245 160 96 26 670
Takanari Harada Japan 10 306 0.8× 221 0.8× 208 0.8× 144 0.9× 92 1.0× 12 545
Sara L. Jepsen Denmark 12 456 1.2× 381 1.3× 249 1.0× 228 1.4× 106 1.1× 19 758
Lina M. Lauffer Germany 9 362 1.0× 258 0.9× 215 0.9× 116 0.7× 95 1.0× 9 650
Jens Pedersen Denmark 9 382 1.0× 339 1.2× 175 0.7× 178 1.1× 61 0.6× 16 599
Dianne Matthews Canada 11 288 0.8× 191 0.7× 139 0.6× 116 0.7× 52 0.5× 15 527
Inmaculada Ruz‐Maldonado United Kingdom 15 253 0.7× 278 1.0× 355 1.4× 213 1.3× 34 0.4× 21 740
Juraj Rievaj United Kingdom 12 157 0.4× 223 0.8× 237 1.0× 162 1.0× 72 0.8× 15 670
Anne K. McGavigan United Kingdom 10 162 0.4× 274 1.0× 179 0.7× 242 1.5× 97 1.0× 13 561
Nadejda Bozadjieva-Kramer United States 18 157 0.4× 369 1.3× 320 1.3× 227 1.4× 88 0.9× 33 763
Antonio S. Rocca Canada 6 385 1.0× 249 0.9× 112 0.5× 175 1.1× 169 1.8× 6 649

Countries citing papers authored by Kimitaka Shibue

Since Specialization
Citations

This map shows the geographic impact of Kimitaka Shibue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimitaka Shibue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimitaka Shibue more than expected).

Fields of papers citing papers by Kimitaka Shibue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimitaka Shibue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimitaka Shibue. The network helps show where Kimitaka Shibue may publish in the future.

Co-authorship network of co-authors of Kimitaka Shibue

This figure shows the co-authorship network connecting the top 25 collaborators of Kimitaka Shibue. A scholar is included among the top collaborators of Kimitaka Shibue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimitaka Shibue. Kimitaka Shibue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shibue, Kimitaka, Sevim Kahraman, Jorge Iván Castillo-Quan, et al.. (2025). Genome-wide CRISPR Screen Identifies Sec31A as a Key Regulator of Alpha Cell Survival. Nature Communications. 16(1). 9159–9159.
2.
Shibue, Kimitaka, et al.. (2025). Conservative Management of Symptomatic Rathke Cleft Cyst With Recurrent Inflammatory Remission. JCEM Case Reports. 3(3). luaf008–luaf008.
3.
4.
Shibue, Kimitaka, et al.. (2024). Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L‐dopa. Journal of Diabetes Investigation. 15(10). 1524–1527. 1 indexed citations
5.
Kahraman, Sevim, Kimitaka Shibue, Dario F. De Jesus, et al.. (2023). Fluorescein-based sensors to purify human α-cells for functional and transcriptomic analyses. eLife. 12. 1 indexed citations
6.
Shibue, Kimitaka, et al.. (2023). A Case of Lymphocytic Infundibulo-neurohypophysitis Exhibiting Spontaneous Regression. JCEM Case Reports. 1(2). luad020–luad020.
7.
Aizawa‐Abe, Megumi, et al.. (2023). Successful Treatment of Postprandial Hyperinsulinemic Hypoglycemia After Billroth-II Gastrojejunostomy Using Octreotide. JCEM Case Reports. 1(6). luad150–luad150. 1 indexed citations
8.
Yoshiji, Satoshi, et al.. (2022). Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study. Diabetes Therapy. 13(4). 733–746. 2 indexed citations
9.
Shibue, Kimitaka, et al.. (2022). Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline. Cureus. 4 indexed citations
10.
Matsuyama, T., Steven K. Yoshinaga, Kimitaka Shibue, & Tak W. Mak. (2021). Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death and Differentiation. 28(12). 3199–3213. 38 indexed citations
11.
Takatani, Tomozumi, Jun Shirakawa, Kimitaka Shibue, et al.. (2021). Insulin receptor substrate 1, but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice. Journal of Biological Chemistry. 296. 100646–100646. 13 indexed citations
12.
Nakayama, Yoichi, Daisuke Taura, Kimitaka Shibue, et al.. (2019). A case of systemic lupus erythematosus complicated by subclinical Cushing’s syndrome: case report. Modern Rheumatology Case Reports. 4(1). 16–20.
13.
Yoshiji, Satoshi, Kimitaka Shibue, Toshihito Fujii, et al.. (2017). Chronic primary adrenal insufficiency after unilateral adrenonephrectomy. Medicine. 96(51). e9091–e9091. 7 indexed citations
14.
Sankoda, Akiko, Norio Harada, Kanako Iwasaki, et al.. (2017). Long-Chain Free Fatty Acid Receptor GPR120 Mediates Oil-Induced GIP Secretion Through CCK in Male Mice. Endocrinology. 158(5). 1172–1180. 54 indexed citations
15.
Joo, Erina, Norio Harada, Shunsuke Yamane, et al.. (2017). Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet–Fed Mice. Diabetes. 66(4). 868–879. 76 indexed citations
16.
Shibue, Kimitaka, Toshihito Fujii, Hisanori Goto, et al.. (2017). Rapid exacerbation of lymphocytic infundibuloneurohypophysitis. Medicine. 96(9). e6034–e6034. 7 indexed citations
17.
Iwasaki, Kanako, Norio Harada, Kazuki Sasaki, et al.. (2014). Free Fatty Acid Receptor GPR120 Is Highly Expressed in Enteroendocrine K Cells of the Upper Small Intestine and Has a Critical Role in GIP Secretion After Fat Ingestion. Endocrinology. 156(3). 837–846. 104 indexed citations
18.
Joo, Erina, Atsushi Muraoka, Akihiro Hamasaki, et al.. (2014). Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon‐like peptide‐2 secretion. Journal of Diabetes Investigation. 6(3). 302–308. 9 indexed citations
19.
Harada, Norio, Takashi Sozu, Akihiro Hamasaki, et al.. (2013). A hospital-based cross-sectional study to develop an estimation formula for 2-h post-challenge plasma glucose for screening impaired glucose tolerance. Diabetes Research and Clinical Practice. 101(2). 218–225.
20.
Suzuki, Kazuyo, Norio Harada, Shunsuke Yamane, et al.. (2012). Transcriptional Regulatory Factor X6 (Rfx6) Increases Gastric Inhibitory Polypeptide (GIP) Expression in Enteroendocrine K-cells and Is Involved in GIP Hypersecretion in High Fat Diet-induced Obesity. Journal of Biological Chemistry. 288(3). 1929–1938. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takanari Harada Breakdown of academic impact, for papers by Sara L. Jepsen Breakdown of academic impact, for papers by Lina M. Lauffer Breakdown of academic impact, for papers by Jens Pedersen Breakdown of academic impact, for papers by Dianne Matthews Breakdown of academic impact, for papers by Inmaculada Ruz‐Maldonado Breakdown of academic impact, for papers by Juraj Rievaj Breakdown of academic impact, for papers by Anne K. McGavigan Breakdown of academic impact, for papers by Nadejda Bozadjieva-Kramer Breakdown of academic impact, for papers by Antonio S. Rocca
Rankless by CCL
2026